-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Antiglaucoma drugs for achieving monovision after laser in situ keratomileusis
Case report
(2653) Views (553) Full article downloads
Authors: Kazutaka Kamiya, Kimiya Shimizu
Published Date February 2009
Volume 2009:3 Pages 211 - 213
DOI: http://dx.doi.org/10.2147/OPTH.S4914
Kazutaka Kamiya, Kimiya Shimizu
Department of Ophthalmology, University of Kitasato School of Medicine, Japan
Abstract: We report on a patient in whom the use of antiglaucoma drugs has been beneficial for the attainment of monovision after laser in situ keratomileusis (LASIK). A 57-year-old woman undergoing LASIK complained of blurred vision in the right eye. After a successful trial of monovision with contact lenses, antiglaucoma drugs (2.5% nipradilol) were administered topically to the right eye twice a day to establish monovision. In the right eye, the manifest refraction was changed from −4.0, −1.0 × 80, with an uncorrected visual acuity (UCVA) of 0.3 for near vision before treatment, to −2.5, −1.0 × 80, with an UCVA of 0.9 for near vision after treatment, while, in the left eye, it was 0, −1.0 × 100, with an UCVA of 0.9 for far vision. Binocular UCVA was improved from 0.3 for near and 0.9 for distance vision before treatment, to 0.9 for near and 1.0 for distance vision after treatment. No complications were observed and the manifest refraction remained stable during the 6-month follow-up period. The use of antiglaucoma drugs may be helpful for the achievement of monovision by reduction of myopic regression after LASIK.
Keywords: antiglaucoma drugs, regression, monovision, LASIK
Other articles by Dr Kazutaka Kamiya
Readers of this article also read:
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Etiology, prevalence, and treatment of dry eye disease
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Spectacle independence and subjective satisfaction of ReSTOR® multifocal intraocular lens after cataract or presbyopia surgery in two European countries
Development of a low-cost confocal instrument to measure the axial dimensions of components in the anterior section of the eye
Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma
Predictive factors of success in selective laser trabeculoplasty (SLT) treatment
Revisiting corneal topography for the diagnosis of keratoconus: use of Rabinowitz's KISA% index
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Insight into 144 patients with ocular vascular events during VEGF antagonist injections
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia




